NKTX
Nkarta, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.83
+0.71%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+1.1%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Jun 22, 2026 | HASTINGS PAUL J · director, officer: Chief Executive Officer | Sale | 1,776 | $2.71 |
| Jun 11, 2026 | Behbahani Ali · director | A-Award | 37,000 | $2.46 |
| Jun 11, 2026 | George Simeon · director | A-Award | 37,000 | $2.46 |
| Jun 11, 2026 | Scheiner Zachary · director | A-Award | 37,000 | $2.46 |
| Jun 11, 2026 | PATTERSON LEONE D · director | A-Award | 37,000 | $2.46 |
| Jun 11, 2026 | Dybbs Michael · director | A-Award | 37,000 | $2.46 |
| Jun 11, 2026 | Thedinga Angela · director | A-Award | 37,000 | $2.46 |
| Jun 11, 2026 | RA CAPITAL MANAGEMENT, L.P. · director, 10 percent owner: | A-Award | 37,000 | $2.46 |
| Jun 11, 2026 | Vratsanos George · director | A-Award | 37,000 | $2.46 |
| Jan 20, 2026 | HASTINGS PAUL J · director, officer: Chief Executive Officer | Sale | 26,046 | $2.07 |
| Jan 20, 2026 | Mahmood Nadir · officer: President | Sale | 5,649 | $2.07 |
| Jan 8, 2026 | HASTINGS PAUL J · director, officer: Chief Executive Officer | A-Award | 94,000 | $0.00 |
| Jan 8, 2026 | Rose Shawn Marshall · officer: See Remarks | A-Award | 70,000 | $0.00 |
| Jan 8, 2026 | Mahmood Nadir · officer: President | A-Award | 80,000 | $0.00 |
| Jan 8, 2026 | Mahmood Nadir · officer: President | A-Award | 160,000 | $1.93 |
| Jan 8, 2026 | HASTINGS PAUL J · director, officer: Chief Executive Officer | A-Award | 562,000 | $1.93 |
| Jan 8, 2026 | Rose Shawn Marshall · officer: See Remarks | A-Award | 139,000 | $1.93 |
| Jun 25, 2025 | Rose Shawn Marshall · officer: See Remarks | A-Award | 500,000 | $1.75 |
| Jun 20, 2025 | HASTINGS PAUL J · director, officer: Chief Executive Officer | Sale | 1,790 | $1.79 |
| Jun 9, 2025 | Dybbs Michael · director | A-Award | 46,000 | $1.83 |
| Jun 9, 2025 | PATTERSON LEONE D · director | A-Award | 46,000 | $1.83 |
| Jun 9, 2025 | George Simeon · director | A-Award | 46,000 | $1.83 |
| Jun 9, 2025 | Behbahani Ali · director | A-Award | 46,000 | $1.83 |
| Jun 9, 2025 | Scheiner Zachary · director | A-Award | 46,000 | $1.83 |
| Jun 9, 2025 | Thedinga Angela · director | A-Award | 46,000 | $1.83 |
| Jun 9, 2025 | Vratsanos George · director | A-Award | 46,000 | $1.83 |
| Jun 9, 2025 | HASTINGS PAUL J · director, officer: Chief Executive Officer | A-Award | 377,000 | $1.83 |
| Jun 9, 2025 | Mahmood Nadir · officer: President | A-Award | 123,500 | $1.83 |
| Jun 9, 2025 | RA CAPITAL MANAGEMENT, L.P. · director, 10 percent owner: | A-Award | 46,000 | $1.83 |
| Jan 17, 2025 | Hager Alicia J. · officer: Chief Legal Officer | Sale | 9,584 | $2.20 |
Institutional positioning
13F filings over the trailing two quarters
New 45Increased 99Reduced 69Sold out 13
| Filer | Action | Shares | Filed |
|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | Unchanged | 10,805,129 | May 15, 2026 |
| RA CAPITAL MANAGEMENT, L.P. | Unchanged | 10,805,129 | Aug 14, 2026 |
| BlackRock, Inc. | Increased | 6,300,212 | Aug 7, 2026 |
| BLACKROCK, INC. | Increased | 4,508,473 | May 13, 2026 |
| NEA MANAGEMENT COMPANY, LLC | Unchanged | 3,568,781 | May 15, 2026 |
| NEA Management Company, LLC | Unchanged | 3,568,781 | Aug 14, 2026 |
| SAMSARA BIOCAPITAL, LLC | Unchanged | 3,507,666 | May 15, 2026 |
| Samsara BioCapital, LLC | Unchanged | 3,507,666 | Aug 14, 2026 |
| SR ONE CAPITAL MANAGEMENT, LP | Unchanged | 3,333,333 | May 14, 2026 |
| SR ONE CAPITAL MANAGEMENT, LP | Unchanged | 3,333,333 | Aug 12, 2026 |
| GSK PLC | Unchanged | 3,150,732 | May 14, 2026 |
| GSK plc | Unchanged | 3,150,732 | Aug 13, 2026 |
| MONACO ASSET MANAGEMENT SAM | Reduced | 2,521,932 | May 11, 2026 |
| Monaco Asset Management SAM | Reduced | 2,373,400 | Aug 7, 2026 |
| CITADEL ADVISORS LLC | Increased | 2,255,745 | Sep 2, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jun 22, 2026